Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q3 2025

Type / Class
Equity / American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share
Symbol
EVAX on Nasdaq
Shares outstanding
315,652,014
Price per share
$3.63
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1,214,128
Total reported value
$4,565,121
Share change
0
Number of holders
2
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Merck & Co., Inc. 20% $105,531,938 63,004,142 Merck & Co., Inc. 31 Jan 2025

As of 30 Sep 2025, 2 institutional investors reported holding 1,214,128 shares of Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX). This represents 0.38% of the company’s total 315,652,014 outstanding shares.

Institutional Holders of Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 1,214,128 $4,565,121 $3.63 2
2025 Q2 1,214,128 $2,974,613 $2.22 2
2025 Q1 1,214,128 $2,246,136 +$1,019,666 $1.68 2
2024 Q4 806,483 $681,502 -$277,603 $0.85 9
2024 Q3 548,474 $1,705,753 +$291,174 $3.11 8
2024 Q2 453,337 $1,313,498 +$206,103 $2.89 6
2024 Q1 381,029 $1,219,293 +$1,212,436 $3.20 6
2023 Q4 10,000 $6,857 +$6,857 $0.69 1